Increasing Autoimmune Disease Studies to Elevate Immunoglobulins Market Prospects: Fact.MR

Surging cases of autoimmune disease is spurring researchers to verify and reintroduce new innovations for the treatment

Fact.MR, Rockville MD: Award winning market research company Fact.MR has conducted a study on the global immunoglobulins market for the upcoming decade. As per its findings, the market is poised to witness credible gains across 2021, as there’s an upsurge in the applications of autoimmune diseases witness an escalating trend. Increased R&D activities from manufacturers will continue exhibiting high growth rate until 2031.

According to the study, the market is likely to build on the new product development and innovation for the treatment of neurological and autoimmune disorders. For instance, in a recent study the U.S. Food and Drug Administration approved for at least 10% of clinical trials to assess the safety and efficiency for IVIG. Hence, propelling the sales for immunoglobulins market.  

Furthermore, a recently initiated clinical study in March 2021 by National Institute of Health stated that over 23.5 million people in U.S suffer from autoimmune diseases such as multiple sclerosis and lupus erythematosus, increasing the manufacturing of IVIG and SCID. As such studies acquire momentum, market penetration of immunoglobulins is bound to broaden the opportunities in upcoming years.

“Key immunoglobulins manufacturers are capitalizing on advanced technology and innovation to provide highly accurate and precision based research, enabling practitioners to provide potential cure for the novel corona virus,” says the Fact.MR analyst.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4788

Key Takeaways

• Immunoglobulins market to exhibit a growth of nearly 7% CAGR through 2021
• By application, neurology segment held 2/5^th of the market share until 2021
• Immunology segment is expected to account for over 35% market share in the upcoming years
• Subcutaneous segment is expected to emerge as a potential owing to the rising cases for neurological disorder
• North America to remain dominant, Asia Pacific to expand at a stellar CAGR of nearly 8.3% through 2021
• By administration route, the intravenous segment to remain lucrative
• Home care segment expected to exhibit a CAGR of nearly 8.3%, accounting for almost 2/5^th of the market share

Prominent Drivers

• Increasing immunodeficiency diseases such as diabetes and AIDS, providing a high pedestal for immunoglobulins market
• Rising need for IVIG for the treatment of autoimmune diseases such as rheumatoid arthritis and chronic lymphocytic lymphoma to foster the sales
• Manufacturers are finding increased opportunities in r&d programs for IVIG and IMIG applications

Key Restraints

• Adverse side effects such as renal impairment, thrombosis to hamper the sales for IVIG application, restraining the growth of immunoglobulins

Discover more about the immunoglobulins market with 104 figures, 24 data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/4788/immunoglobulins-market

Competitive Landscape

Key Immunoglobulins market players profiled by Fact.MR include Shire, CSL Behring, Kedrion Biopharma Inc., Grifols S.A., Octapharma, China Biologic Products Holdings Inc., Biotest AG, Sanquin and LFB SA among others.

For instance, in March 2021, Grifols reinforced its innovation strategy after completing the aqcuisition of GigaGen to boost a novel method to generate a wide range of immunoglobulin. Grifols acquired the remaining share capital of the U.S biopharmaceutical company for $80 million.

Also, GigaGen, a U.S. biotechnology company with the collaboration of Grifols are focusing on developing new biological treatments based on antibodies derived from millions of immune system cells obtained from donors. Hence, continuing to prioritize its strategy as a core pillar for sustainable growth.

More Insights on the Immunoglobulins Market

In its latest report, Fact.MR offers unbiased analysis of the global Immunoglobulins market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of application (neurology, immunology, hematology, and others), route of administration (intravenous, subcutaneous, and intramuscular), end-user (hospitals, clinics and homecare), and key regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Get Customization on this Report for Specific Research Solution

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4788

Explore Fact.MR’s Coverage on the Healthcare Domain

Cancer immunotherapy Market: A recent study by Fact.MR on the Cancer immunotherapy market offers a 10-year forecast. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Chemiluminescence Immunoassay (CLIA) Analyzers Market: A detailed assessment of Chemiluminescence Immunoassay (CLIA) Analyzers value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the Chemiluminescence Immunoassay (CLIA) Analyzers market along with their product portfolios enhances the reliability of this comprehensive research study.  

Immunoassay Market: Fact.MR has published an exhaustive market study on the global market for immunoassay. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the mycoplasma detection market structure. 

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.    

Contact:
Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Source: Fact.MR